cdna
compris
complet
genom
west
nile
viru
wnv
gener
chemic
synthesi
use
publish
sequenc
data
independ
preform
viral
compon
synthet
wnv
produc
transfect
vitro
transcrib
rna
cell
cultur
exhibit
undistinguish
biolog
properti
compar
correspond
animalderiv
wildtyp
viru
differ
found
concern
viral
growth
mammalian
insect
cell
line
concern
express
viral
protein
cell
also
signific
differ
virul
mice
follow
intranas
challeng
immun
mice
experiment
vaccin
deriv
synthet
wildtyp
virus
protect
lethal
challeng
achiev
similar
amount
antigen
vaccin
prepar
also
induc
compar
level
neutral
antibodi
mice
addit
synthet
approach
turn
accur
sinc
rescu
wnv
genom
contain
undesir
mutat
thu
first
flaviviru
base
chemic
gene
synthesi
indistinguish
parent
viru
demonstr
viru
isol
anim
sourc
dispens
deriv
seed
virus
vaccin
product
research
west
nile
viru
wnv
mosquitoborn
neurotrop
member
genu
flaviviru
famili
flavivirida
identifi
africa
europ
middl
east
south
central
asia
oceania
subtyp
kunjin
recent
north
america
review
us
wnv
activ
human
bird
companion
anim
mosquito
report
sinc
center
diseas
control
cdc
almost
state
besid
wnv
genu
flaviviru
compris
number
medic
import
pathogen
includ
japanes
enceph
viru
jev
yellow
fever
viru
yfv
tick
born
enceph
viru
tbev
four
serotyp
dengu
viru
denv
flaviviru
genom
positivepolar
singlestrand
rna
molecul
nucleotid
nt
function
mrna
translat
viral
protein
genom
rna
infecti
introduc
suscept
cell
transfect
replic
pathogenesi
studi
revers
genet
system
establish
sever
member
genu
system
compris
one
two
plasmid
encod
cdna
viral
genom
sequenc
control
bacteriophag
promot
allow
transcript
fulllength
infecti
rna
vitro
yfv
tbev
kun
mve
wnv
lineag
ii
cdna
compris
full
genom
stabli
clone
bacteri
express
plasmid
wherea
report
cdna
split
two
fragment
integr
individu
plasmid
cdna
fuse
togeth
rna
transcript
altern
approach
appli
construct
jev
infecti
clone
viral
code
sequenc
put
control
eukaryot
promot
split
intron
circumv
instabl
propag
bacteria
convent
gener
cdna
clone
requir
product
initi
viru
stock
viral
rna
isol
revers
transcript
pcr
amplif
subfrag
engin
final
transcript
unit
approach
sometim
hamper
low
fidel
revers
transcriptas
sequenc
variat
start
isol
may
lead
undesir
alter
genom
sequenc
consequ
report
viral
cdna
clone
gener
virus
analyz
sequenc
analysi
nucleotid
variat
detect
compar
publish
sequenc
parent
viru
landmark
public
prove
feasibl
de
novo
synthesi
polioviru
biochem
synthesi
preclud
preform
compon
viral
cdna
encod
kb
genom
assembl
overlap
oligonucleotid
yield
infecti
viru
transcript
genom
rna
inocul
cell
lysat
take
advantag
rapid
progress
gene
synthesi
technolog
review
intend
adopt
synthet
approach
produc
flaviviru
cdna
system
gener
synthet
wnv
seed
viru
use
vaccin
develop
studi
report
gener
fulli
function
wnv
viru
complet
synthet
sourc
whole
wnv
genom
sequenc
gener
gene
synthesi
without
use
natur
viral
templat
product
character
result
west
nile
viru
fulli
match
sequenc
silico
design
viral
genom
confirm
feasibl
accuraci
synthet
flaviviru
revers
genet
system
wnv
wildtyp
viru
strain
obtain
center
diseas
control
cdc
atlanta
correspond
genbank
access
sequenc
inform
also
use
templat
silico
design
de
novo
synthesi
genom
cdna
cell
line
vero
atcc
bhk
atcc
eceacc
obtain
american
type
cultur
collect
european
collect
cell
cultur
grown
dubecco
modifi
eagl
medium
dmem
tcvero
media
baxter
tcvero
anim
proteinfre
medium
base
dmemham
medium
six
dna
fragment
correspond
wnv
strain
genbank
access
gener
chemic
synthesi
geneart
regensburg
germani
plasmid
tlab
carri
dna
correspond
wnv
genom
sequenc
nt
plasmid
tlcd
nt
plasmid
tlab
nt
plasmid
tlcd
nt
plasmid
tlef
nt
plasmid
tlgh
nt
three
silent
mutat
posit
introduc
knock
ecori
site
creat
styi
site
describ
previous
assembl
plasmid
tl
contain
third
wnv
code
sequenc
asci
bsai
cut
fragment
tlab
ligat
bbsi
paci
cut
fragment
tlcd
fig
ligat
product
amplifi
use
high
fidel
pcr
kod
invitrogen
follow
digest
bamhi
xbai
fragment
clone
low
copi
plasmid
vector
deriv
plasmid
engin
contain
match
polylink
uniqu
restrict
site
eagi
result
partial
delet
tet
r
gene
yield
tl
plasmid
contain
twothird
wnv
code
sequenc
gener
three
step
asci
bsai
cut
fragment
tlab
ligat
bsai
paci
cut
fragment
tlcd
fragment
amplifi
high
fidel
pcr
integr
commerci
avail
ppcrscript
vector
clontech
ii
btgzi
asci
cut
fragment
tlef
ligat
paci
btgzi
cut
fragment
tlgh
result
tlefgh
ligat
product
amplifi
pcr
use
flank
primer
digest
spei
xbai
integr
lead
plasmid
tl
efgh
fig
iii
final
tl
gener
introduct
tlabcd
fragment
deriv
tlabcd
tlefgh
take
advantag
uniqu
restrict
enzym
spei
bamhi
fig
plasmid
amplifi
bacteri
strain
promega
purifi
commerci
avail
system
omega
qiagen
electropor
bacteri
cell
carri
use
genepuls
apparatu
biorad
set
kv
f
sequenc
analysi
carri
use
genet
analyz
abi
use
bigdy
termin
cycl
sequenc
kit
abi
tl
linear
xbai
follow
mung
bean
nucleas
digest
remov
singl
strand
nucleotid
overhang
order
gener
correct
end
wnv
code
sequenc
plasmid
tl
tl
digest
sphi
fulllength
sequenc
gener
ligat
ligas
new
england
biolab
via
sphi
sequenc
overhang
part
ligat
dna
fragment
extract
phenolchloroform
twice
precipit
ethanol
resuspend
nucleas
free
water
rna
transcrib
c
h
ligat
templat
dna
polymeras
transcript
use
megascript
kit
ambion
integr
rna
transcript
analyz
agaros
gel
contain
formaldehyd
rna
transfect
subconflu
vaccinecertifi
vero
cell
collect
trypsin
wash
twice
serum
free
tc
vero
medium
baxter
twice
icecold
pb
buffer
aliquot
approxim
cell
resuspend
l
icecold
pb
mix
transcrib
rna
transfer
gene
pulser
cuvett
cell
electropor
three
success
puls
use
genepuls
apparatu
biorad
set
kv
f
visual
intracellular
express
wnv
protein
cell
infect
transfect
two
day
later
cell
fix
acetonemethanol
cover
slip
fix
cell
dri
rehydr
phosphatebuff
salin
treat
polyclon
mous
antiwnv
serum
dilut
obtain
immun
mice
formalininactiv
whole
viru
vaccin
prepar
bound
antibodi
visual
fluorescein
isocyanateconjug
antimous
immunoglobulin
dilut
jackson
research
laboratori
vero
cell
grown
cm
tissu
cultur
flask
infect
either
wnvsyn
wnvwt
stock
moi
inoculum
remov
h
ml
fresh
medium
ad
variou
time
point
h
ml
medium
remov
infecti
viru
titer
wnv
contain
sampl
determin
tcid
assay
brief
serial
dilut
viru
contain
supernat
inocul
microtit
plate
seed
vero
cell
incub
day
c
co
plate
screen
light
microscop
presenc
cpe
individu
well
number
cpe
posit
well
per
dilut
step
tcid
calcul
accord
poisson
formula
mean
hous
calcul
softwar
program
viral
rna
extract
supernat
contain
viral
materi
correspond
tcid
trizol
extract
rna
precipit
ethanol
rna
pellet
resuspend
l
nucleasefre
water
one
l
rna
use
cdna
transcript
use
superscript
iii
cdna
synthesi
kit
invitrogen
primer
bind
end
code
region
code
region
noncod
region
gener
inactiv
whole
viru
vaccin
wnvsyn
wnvwt
stock
amplifi
bhk
cell
serv
primeboost
antigen
anim
studi
wnvsyn
prepar
design
cag
well
wnvwt
prepar
design
cag
prepar
manner
ten
roller
bottl
bhk
cell
infect
moi
better
viru
yield
ph
adjust
h
viru
adsorpt
day
growth
supernat
harvest
clear
low
spin
centrifug
step
rpm
clear
supernat
treat
formalin
final
concentr
h
next
ml
inactiv
viru
load
ml
sucros
cushion
per
centrifug
tube
beckman
tube
h
centrifug
g
supernat
discard
result
pellet
pool
tri
buffer
salin
tb
aliquot
result
vaccin
prepar
subject
safeti
assay
exclud
possibl
remain
infect
order
normal
administ
amount
antigen
given
immunogen
studi
antigen
content
determin
wnvspecif
antigen
elisa
lethal
dose
ld
determin
femal
balbc
mice
group
six
mice
infect
intranas
tcid
wnvsyn
wnvwt
respect
surviv
mice
record
period
day
infect
viru
dilut
titrat
shortli
challeng
use
calcul
ld
valu
use
comput
program
graph
pad
prism
protect
determin
immun
femal
balbc
mice
subcutan
inject
formalininactiv
wnvsyn
wnvwt
vaccin
volum
l
tb
contain
al
oh
mice
challeng
intranas
l
pb
human
serum
albumin
contain
tcid
wnvwt
viru
surviv
monitor
period
day
challeng
neutral
antibodi
determin
serum
sampl
serial
dilut
cell
cultur
medium
twofold
step
serum
dilut
mix
ratio
viru
stock
suspens
adjust
tcid
incub
min
room
temperatur
transfer
eight
replic
per
dilut
microtit
plate
seed
vero
cell
plate
inspect
light
microscop
presenc
cpe
incub
day
c
co
neutral
titer
calcul
count
cpe
neg
well
usag
formula
nttiter
wherea
nneg
amount
neg
well
v
repres
dilut
sera
neutral
mix
assay
defin
serum
posit
control
measur
titer
viral
materi
titrat
detect
infecti
viral
materi
formalininactiv
wnv
antigen
prepar
vero
cell
seed
five
cm
tissu
cultur
flask
inocul
individu
prepar
correspond
ml
infecti
yield
prepar
deriv
day
incub
period
c
co
supernat
flask
titrat
tcid
ml
supernat
flask
carri
onto
fresh
vero
cell
observ
period
supernat
flask
titrat
tcid
respect
antigen
prepar
classifi
safe
cpe
detect
individu
flask
viral
materi
detect
tcid
assay
amount
wnv
antigen
respect
sampl
determin
mean
elisa
doubl
sandwich
system
briefli
microtit
plate
coat
overnight
incub
c
antiwnv
igg
polyclon
serum
rais
guinea
pig
subsequ
wash
step
serial
twofold
dilut
standard
west
nile
viru
product
materi
wnv
peak
pool
defin
antigen
amount
control
sampl
individu
sampl
appli
microtit
plate
incub
h
c
subsequ
wash
step
mous
antiwnv
polyclon
serum
appli
well
incub
h
c
wash
well
incub
horseradish
peroxidaseconjug
donkey
antimous
igg
jackson
immuno
research
laboratori
h
c
subsequ
wash
step
substrat
ophenylenediamineh
ad
enzym
reaction
stop
min
c
addit
h
absorb
nm
measur
elisa
plate
reader
biotek
winooski
vt
usa
antigen
content
calcul
softwar
biotek
mean
standard
curv
deriv
dilut
step
wnv
peak
pool
standard
materi
anim
experi
review
institut
anim
care
use
committe
iacuc
approv
austrian
regulatori
author
conduct
accord
austrian
law
anim
experiment
guidelin
set
associ
assess
accredit
laboratori
anim
care
aaalac
anim
hous
facil
accredit
aaalac
experi
infecti
viru
carri
biosafeti
level
condit
experi
approv
baxter
intern
biosafeti
committe
austrian
ministri
health
construct
bipartit
infecti
clone
six
contigu
cdna
fragment
encod
genom
lineag
wnv
strain
chemic
synthes
integr
bacteri
express
plasmid
see
section
accord
clone
strategi
outlin
fig
three
silent
marker
mutat
introduc
see
also
allow
discrimin
synthet
viru
correspond
wildtyp
isol
see
tabl
six
synthet
gener
wnv
subfrag
ligat
stepwis
result
two
plasmid
correspond
part
complet
genom
wnv
sequenc
purpos
either
uniqu
restrict
site
wnv
sequenc
use
appropri
asymmetr
restrict
site
gener
plasmid
vector
backbon
adjac
wnv
fragment
cleavag
asymmetr
site
creat
overhang
wnv
sequenc
correspond
fragment
could
fuse
togeth
follow
strategi
two
plasmid
gener
contain
either
third
nt
control
promot
twothird
nt
wnv
genom
sequenc
design
tl
tl
respect
clone
step
evalu
complet
sequenc
cdna
insert
undesir
sequenc
alter
observ
final
two
plasmid
nucleotid
alter
found
except
intend
silent
marker
mutat
analyz
function
cdna
system
rna
transcript
correspond
entir
genom
wnv
gener
fulllength
wnv
cdna
templat
obtain
ligat
tl
tl
genom
length
viral
rna
transcrib
integr
rna
transcript
analyz
agaros
gel
contain
formaldehyd
rna
band
approxim
nucleotid
obtain
indic
presenc
wnv
fulllength
rna
data
shown
character
abil
transcrib
rna
replic
translat
introduct
host
cell
viral
protein
express
examin
immunofluoresc
stain
wnvsyn
rna
electropor
vero
cell
subject
indirect
stain
day
later
fig
viral
protein
express
monitor
specif
polyclon
mous
antiwnv
antibodi
fitcconjug
second
antibodi
see
section
cell
infect
moi
wnvwt
use
stain
control
wnvsyntransfect
wnvwtinfect
vero
cell
exhibit
wnv
protein
express
approxim
cell
expect
viral
antigen
stain
mainli
confin
perinuclear
region
cell
fig
immunofluoresc
stain
detect
replicationand
translationcompet
viral
templat
could
shown
replicationdefici
mutant
viral
genom
thu
prove
replic
protein
express
capac
synthet
wnv
genom
order
analyz
genotyp
phenotyp
properti
stock
synthet
wnv
produc
confluent
vero
cell
transfect
describ
upon
onset
cytopath
effect
cpe
day
cell
cultur
medium
harvest
viru
titer
determin
vero
cell
yield
titer
tcid
ml
overlap
dna
fragment
cover
whole
wnvsyn
genom
code
region
amplifi
pcr
cdna
transcript
isol
viral
rna
sequenc
confirm
rescu
viral
materi
contain
mutat
compar
silico
design
wnv
genom
presenc
engin
nucleotid
chang
prove
ident
synthet
viru
addit
order
show
stain
behavior
vero
cell
transfect
rna
cell
infect
moi
wnvsyn
process
describ
expect
wnvsyn
viru
stock
gave
rise
similar
stain
pattern
seen
wnvwt
stock
fig
order
analyz
growth
properti
wnvsyn
wnvwt
one
step
growth
curv
carri
suscept
mammalian
vero
mosquito
cell
infect
moi
viral
titer
determin
time
point
indic
fig
demonstr
cell
type
growth
kinet
wnvsyn
match
exactli
wildtyp
viru
addit
plaqu
morpholog
fig
b
cpe
shown
compar
wildtyp
control
viru
grown
vero
cell
peak
h
posttransfect
declin
day
correl
onset
cpe
infect
cell
day
fig
growth
kinet
mosquito
cell
delay
observ
other
reach
equal
titer
compar
vero
cell
day
postinfect
fig
taken
togeth
data
indic
wnvsyn
correspond
wnvwt
isol
indistinguish
respect
replic
infect
test
cell
line
addit
virul
wnvsyn
wnvwt
compar
cohort
balbc
mice
purpos
mice
infect
intranas
viru
dilut
correspond
tcid
per
anim
surviv
monitor
day
postinfect
ld
valu
calcul
similar
mortal
infect
mice
induc
two
wnv
virus
observ
tabl
lethal
dose
wnvsyn
wnvwt
tabl
virul
wnvsyn
wnvwt
intranas
applic
balbc
mice
log
tcid
respect
experi
repeat
similar
result
obtain
follow
demonstr
wnvsyn
exhibit
indistinguish
biolog
properti
compar
wnv
wildtyp
isol
protect
efficaci
experiment
vaccin
deriv
virus
analyz
purpos
group
ten
mice
immun
twice
decreas
dose
formalininactiv
alumadjuv
whole
viru
vaccin
deriv
virus
see
section
quantif
elisa
vaccin
prepar
prior
formul
adjuvant
confirm
presenc
equal
amount
antigen
respect
dosag
group
western
blot
confirm
equival
amount
protein
pattern
two
antigen
prepar
fig
predomin
band
prepar
envelop
antigen
e
migrat
kda
rang
fainter
band
repres
premembran
prm
dimer
membran
protein
see
also
two
week
second
vaccin
wnvspecif
neutral
antibodi
determin
microneutr
assay
serum
analysi
demonstr
high
neutral
antibodi
level
vaccin
prepar
see
fig
tabl
mice
challeng
intranas
lethal
dose
tcid
wnv
wildtyp
viru
vaccin
prepar
result
high
degre
protect
vaccin
mice
complet
protect
achiev
use
dose
low
nanogram
wnv
antigen
nonvaccin
control
die
vaccin
clearli
induc
dosedepend
protect
correl
nt
titer
tabl
revers
genet
system
positivesens
rna
virus
allow
instanc
mutagenesi
procedur
gener
chimer
virus
thu
invalu
tool
live
vaccin
develop
studi
biolog
virus
see
eg
ref
usual
start
materi
gener
seed
virus
vaccin
revers
genet
system
viru
stock
deriv
biolog
sourc
viru
plaquepurifi
viral
rna
isol
transcrib
cdna
amplifi
pcr
turn
get
assembl
dna
copi
viral
genom
approach
bear
risk
introduc
mutat
select
via
plaqu
purif
step
minim
type
mutat
chose
gener
revers
genet
system
use
differ
approach
independ
preform
viral
rna
compon
anim
sourc
feasibl
gener
system
chemic
synthesi
dna
proven
previous
instanc
gener
polioviru
bacteriophag
spanish
influenza
viru
sarslik
coronaviru
basi
studi
report
first
time
gener
nucleotid
long
synthet
genom
member
famili
flavivirida
sequenc
data
genbank
refer
lineag
west
nile
viru
strain
use
templat
silico
design
clone
strategi
rna
virus
replic
genom
error
prone
mechan
review
see
result
multitud
distinct
relat
nucleic
acid
form
quasispeci
sequenc
viru
genom
usual
clone
plaqu
purif
prior
sequenc
analysi
consist
million
molecul
result
consensu
sequenc
repres
major
genotyp
defin
biolog
properti
biolog
properti
may
chang
instanc
pressur
impos
host
select
chang
genom
sequenc
visibl
new
consensu
sequenc
sequenc
analysi
clone
propag
step
mutat
chang
wildtyp
consensu
sequenc
introduc
pcr
use
synthet
templat
verifi
nucleotid
sequenc
prove
accuraci
approach
thu
synthet
progeni
viru
biolog
indistinguish
natur
parent
experiment
inactiv
vaccin
deriv
wnvwt
wnvsyn
highli
immunogen
anim
vaccin
prepar
induc
compar
level
neutral
antibodi
led
similar
protect
result
low
dose
group
protect
studi
differ
observ
explain
experiment
condit
inher
inaccuraci
biolog
system
rather
genet
differ
two
virus
addit
viru
stock
indistinguish
concern
virul
mice
progress
synthet
biolog
rais
biosecur
concern
possibl
synthes
pathogen
without
need
natur
sourc
instanc
virus
select
agent
list
result
expans
potenti
avail
select
agent
defin
biolog
agent
toxin
regul
us
select
agent
rule
potenti
pose
sever
threat
public
anim
plant
health
us
govern
develop
guidanc
address
issu
wnv
although
biosafeti
level
viru
endem
larg
part
world
belong
select
agent
howev
flavivirus
belong
tickborn
enceph
viru
complex
list
construct
infecti
flavivirus
involv
dna
synthesi
clone
assembl
larger
unit
vitro
transcript
transfect
step
complex
task
done
profession
environ
recent
review
synthet
virus
discuss
dual
use
concern
detail
vaccin
manufactur
import
advantag
use
primari
seed
viru
stock
deriv
gene
synthesi
exclus
potenti
contamin
unknown
known
adventiti
agent
includ
transmiss
spongiform
encephalopathi
agent
mayb
coisol
animalderiv
virus
host
cell
furthermor
approach
render
passag
plaqu
purif
step
achiev
satisfactori
puriti
seed
virus
anim
sourc
unnecessari
studi
demonstr
feasibl
gener
flaviviru
wnv
complet
synthet
approach
synthet
biolog
therefor
valuabl
altern
obtain
viral
seed
stock
free
adventiti
agent
might
accompani
recoveri
vertebr
insect
cell
